日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Factor VIII and von Willebrand factor activity levels during long-term prophylaxis with wilate-Analyses from the WIL-31 study

长期使用 WIlate 进行预防期间因子 VIII 和血管性血友病因子活性水平的变化——来自 WIL-31 研究的分析

期刊:Research and Practice in Thrombosis and Haemostasis
影响因子:3.4
doi:10.1016/j.rpth.2025.103327
Sidonio, Robert F Jr; Boban, Ana; Djambas Khayat, Claudia
IL-3
IL-31
发表日期：2026
文献求助 收藏

Prophylaxis for von Willebrand disease: Is it time for parity with established practice in hemophilia A?

预防血管性血友病：是否应该与 A 型血友病的既定做法保持一致？

期刊:Therapeutic Advances in Hematology
影响因子:3.1
doi:10.1177/20406207261431617
Sidonio, Robert F Jr; Corrales-Medina, Fernando F; Johnsen, Jill M; Sholzberg, Michelle; Malcolmson, Caroline; Connell, Nathan T
发表日期：2026
文献求助 收藏

Efficacy and Safety of Prophylaxis With a Plasma-Derived von Willebrand Factor/Factor VIII Concentrate (Wilate) in Patients With Type 3 von Willebrand Disease-A WIL-31 Study Sub-Analysis

血浆来源的血管性血友病因子/因子VIII浓缩物（Wilate）预防治疗在3型血管性血友病患者中的疗效和安全性——WIL-31研究亚组分析

期刊:European Journal of Haematology
影响因子:2.3
doi:10.1111/ejh.70117
Djambas Khayat, Claudia; Dubey, Leonid; Inati, Adlette; Lissitchkov, Toshko; Novik, Dzmitry; Peteva, Elina; Sidonio, Robert F Jr; Taher, Ali T; Vilchevska, Kateryna V; Vdovin, Vladimir; Boban, Ana
IL-3
IL-31
发表日期：2026
文献求助 收藏

Efficacy and safety of plasma-derived von Willebrand factor/factor VIII concentrate (wilate) prophylaxis in children and adolescents with von Willebrand disease - WIL-31 study post hoc analysis

血浆来源的血管性血友病因子/因子VIII浓缩物（WIlate）预防治疗在儿童和青少年血管性血友病中的疗效和安全性——WIL-31研究事后分析

期刊:Research and Practice in Thrombosis and Haemostasis
影响因子:3.4
doi:10.1016/j.rpth.2025.102719
Sidonio, Robert F Jr; Dubey, Leonid; Vilchevska, Kateryna V; Inati, Adlette; Djambas Khayat, Claudia
IL-3
IL-31
发表日期：2025
文献求助 收藏

Individualizing dosing frequency may improve the efficacy of prophylaxis in patients with von Willebrand disease-a WIL-31 subanalysis

个体化给药频率可能提高血管性血友病患者的预防效果——一项WIL-31亚组分析

期刊:Research and Practice in Thrombosis and Haemostasis
影响因子:3.4
doi:10.1016/j.rpth.2025.103221
Sidonio, Robert F Jr; Boban, Ana; Lissitchkov, Toshko; Nemes, Laszlo; Vdovin, Vladimir; Khayat, Claudia Djambas
IL-3
IL-31
发表日期：2025
文献求助 收藏

Activated prothrombin complex concentrate in patients receiving emicizumab prophylaxis: from evidence to clinical practice

接受艾美赛珠单抗预防治疗的患者中活化凝血酶原复合物浓缩物的应用：从循证医学到临床实践

期刊:Research and Practice in Thrombosis and Haemostasis
影响因子:3.4
doi:10.1016/j.rpth.2025.102926
Sidonio, Robert F Jr; Young, Guy; Escuriola Ettingshausen, Carmen; Mahlangu, Johnny; Ozelo, Margareth C; Srivastava, Alok; Windyga, Jerzy; Lee, Hye-Youn; Lelli, Aurelia; Pipe, Steven W
发表日期：2025
文献求助 收藏

von Willebrand Factor (VWF) Inhibitors in Two Brothers with von Willebrand Disease: A Case Report

两兄弟患有血管性血友病，使用血管性血友病因子（VWF）抑制剂的病例报告

期刊:TH Open
影响因子:1.8
doi:10.1055/a-2606-9625
Djambas Khayat, Claudia; Pavlova, Anna; Werner, Sylvia; Knaub, Sigurd; Sidonio, Robert F Jr
VWF
发表日期：2025
文献求助 收藏

Treatment of severe bleeds with eptacog beta in hemophilia A or B with inhibitors: a post hoc analysis of the PERSEPT 1 and 2 trials

使用依普塔可格β治疗伴有抑制因子的A型或B型血友病患者的严重出血：PERSEPT 1和2试验的事后分析

期刊:
影响因子:
doi:10.1016/j.bvth.2025.100069
Young, Guy; Mahlangu, Johnny; Boggio, Lisa N; Carcao, Manuel; Dargaud, Yesim; Escobar, Miguel; Giermasz, Adam; Hermans, Cédric; Kuriakose, Philip; Miesbach, Wolfgang; Nance, Danielle; Rafique, Amina; Sidonio, Robert F Jr; Vilchevska, Kateryna V; Wang, Michael; Pipe, Steven W
发表日期：2025
文献求助 收藏

Efficacy of regular prophylaxis with a plasma-derived von Willebrand factor/factor VIII concentrate with a 1:1 activity ratio in reducing heavy menstrual bleeding in girls/women with von Willebrand disease

使用活性比为 1:1 的血浆来源的血管性血友病因子/因子 VIII 浓缩物进行常规预防，可有效减少患有血管性血友病的女孩/女性的月经过多。

期刊:AJOG Global Reports
影响因子:
doi:10.1016/j.xagr.2025.100501
Kiss, Csongor; Boda, Zoltan; Khayat, Claudia Djambas; Boban, Ana; Dubey, Leonid; Sidonio, Robert F Jr
发表日期：2025
文献求助 收藏

Duration of anticoagulation for venous thromboembolism in pediatric patients: Evaluation of the Duration of Therapy for Thrombosis in Children (Kids-DOTT) trial outcomes at 2 years

儿童静脉血栓栓塞症抗凝治疗持续时间：儿童血栓治疗持续时间（Kids-DOTT）试验2年结果评估

期刊:Journal of Thrombosis and Haemostasis
影响因子:
doi:10.1016/j.jtha.2024.09.038
Goldenberg, Neil A; Schulman, Sam; Kittelson, John M; Abshire, Thomas C; Casella, James F; Dale, Rita; Halperin, Jonathan L; Hanson, Jade; Kessler, Craig M; Manco-Johnson, Marilyn J; McDevitt, Laurel; Sidonio, Robert F; Spyropoulos, Alex C; Steg, P Gabriel; Bonaca, Marc P
心血管
发表日期：2025
文献求助 收藏